Lu Daopei Hematology Hospital
| China | Turquia | Áustria | |
| Transplante de medula óssea | de $55,000 | de $36,000 | de $140,000 |
| Transplante alogénico de medula óssea de dador relacionado | de $78,000 | de $65,000 | de $150,000 |
| Transplante alogénico de medula óssea de dador não relacionado | de $82,000 | de $80,000 | de $180,000 |
| Terapia com células T CAR | de $165,000 | de $150,000 | de $350,000 |
| Terapia biológica | de $5,800 | de $5,500 | de $20,000 |
A Bookimed não adiciona taxas extras aos preços de tratamento de Oncologia Hematológica. As tarifas vêm das listas oficiais das clínicas. O pagamento é feito diretamente na clínica na chegada ao país.
A Bookimed está comprometida com sua segurança. Trabalha apenas com instituições que mantêm altos padrões internacionais no tratamento de Oncologia Hematológica e têm as licenças necessárias para atender pacientes internacionais em todo o mundo.
A Bookimed oferece assistência gratuita de especialistas. Um coordenador médico pessoal apoia antes, durante e após o tratamento, solucionando problemas. Nunca está sozinho em sua jornada de tratamento de Oncologia Hematológica.
Professor Shixin Liu, MD, PhD, is the Discipline Leader of the Oncology Center. He is the former President of Jilin Provincial Cancer Hospital and former Director of the Cancer Prevention and Treatment Research Institute. He is a second-level professor and doctoral supervisor. He has received the State Council Special Government Allowance, the 4th National Famous Doctor (Outstanding Contribution) award, and the Model of Medical Ethics honor.
He specializes in the comprehensive diagnosis and treatment of malignant tumors. His focus is precision radiotherapy for thoracic and abdominal cancers. He is skilled in IMRT, VMAT, and SBRT for lung, esophageal, breast, and rectal cancers.
His leadership roles include Vice Chair of CMA Radiation Oncology, CACA Radiotherapy, and CACA Particle Therapy. He serves on the CSCO Standing Committee and as Vice Chair of the CSCO Radiation Oncology Expert Committee. He is Vice Chair of CPAM Radiation Oncology and a Standing Committee member of CSMEA. He chairs the Jilin Medical Association Radiation Oncology branch. He is on the editorial boards of the Chinese Journal of Radiation Oncology and the Practical Journal of Cancer.
China integrates Traditional Chinese Medicine (TCM) into oncology through a dual-track system combining Western surgery or chemotherapy with herbal restorative care. This multidisciplinary model aims to eliminate tumors while rebuilding the immune system. Between 64% and 80% of Chinese cancer patients use TCM during treatment.
Bookimed Expert Insight: While many expect TCM to be an alternative, China's elite Class A Level III hospitals, like Yanda International, treat it as a mandatory clinical standard. Data shows these top-tier centers use TCM to stabilize blood counts faster after intensive procedures. Patients should prioritize JCI-accredited facilities to ensure herbal potency is strictly regulated alongside Western diagnostics.
Patient Consensus: Patients note that TCM is culturally essential in China and helps make side effects from treatments like rituximab feel much milder. However, they emphasize the need to monitor liver function closely when using herbal formulas alongside active chemotherapy.
Doctors in China assess hematology-oncology treatment using blood tests, medical imaging, and bone marrow biopsies. These tests track tumor shrinkage and blood cell normalization. Specialized centers like Lu Daopei Hematology Hospital use high-volume data to monitor response. They focus on cellular recovery and genetic markers.
Bookimed Expert Insight: Quality signals in China often correlate with hospital scale and specialized focus. Lu Daopei Hematology Hospital manages 200,000 patients annually across 30 departments. This massive volume allows doctors like Dr. Lu Peihua to recognize subtle response patterns faster. Large-scale facilities often provide quicker test turnarounds than smaller general clinics.
Patient Consensus: Patients note that physical signs like improved energy and reduced bruising often appear before laboratory shifts. They emphasize that regular blood draws are the primary way doctors track early progress between major scans.
International patients typically require an S1 or S2 Private Affairs visa for oncology treatment in China. The S2 visa covers stays under 180 days for surgeries. The S1 visa is for longer treatments exceeding 180 days. Both versions require an official invitation from a government-accredited hospital.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital or Xiamen Humanity Hospital handle over 1,000,000 patients annually. These Class A Level 3 facilities have dedicated departments to streamline visa invitations. This institutional support is vital because they can help convert initial entry visas into medical residency permits once treatment begins.
Patient Consensus: Patients note that hospital-sponsored invitations are more reliable than standard tourist visas for long oncology stays. They emphasize that while some enter on tourist visas, upgrading internally is necessary to avoid deportation during intensive treatment cycles.
English-speaking support in Chinese hematology oncology centers varies significantly by facility type. Top-tier institutions like Fuda Cancer Hospital and Yanda International Hospital hold JCI accreditation. These centers frequently provide dedicated international departments. Staff in these wings often speak English to assist the 30,000+ international patients treated annually.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital manage over 2,500,000 patients annually. Our data shows these `Class A level III` clinics are the most likely to have formal translation infrastructure. If you choose a specialized center like Lu Daopei, we recommend confirming support in writing before your stay. This ensures complex hematology protocols are clearly understood by all parties.
Patient Consensus: Patients note that while top doctors may speak basic English, daily care often requires translation apps like Pleco. It is helpful to prepare Mandarin terms for specific conditions like neutropenia or chemotherapy side effects before arrival.
Patients should plan to stay in China for 3 to 10 weeks for hematology-oncology care. Initial evaluations typically take 3 to 7 days. Advanced treatments like CAR-T cell therapy require 4 to 10 weeks for cell engineering and post-infusion monitoring.
Bookimed Expert Insight: High-volume centers like Yanda International Hospital and Xiamen Humanity Hospital manage over 1,000,000 patients annually. This massive scale allows JCI-accredited facilities to offer thousands of modern technologies and drug trials that may not be available elsewhere. Patients should verify their specific treatment regimen early, as initial plans can change once on-site diagnostics are completed by specialists like Dr. Lu Peihua.
Patient Consensus: Patients emphasize budgeting an extra 2 weeks for potential appointment backlogs and recovery delays. It is highly recommended to hire a Mandarin-speaking medical translator and arrange long-term apartment housing near the hospital for comfort.
Family members can generally stay with you in Chinese hematology-oncology facilities. Policies vary by hospital type and room category. International-standard centers like Fuda Cancer Hospital offer more flexibility. Specialized units have stricter rules to protect immuno-compromised patients. General visiting hours usually run from 8 a.m. to 8 p.m.
Bookimed Expert Insight: Data from high-volume centers like Yanda International Hospital, which serves 2,500,000 patients annually, shows a preference for integrated care. Facilities with JCI accreditation typically offer better infrastructure for families. If family presence is your priority, look for clinics with over 1,000 beds. These larger campuses often include on-site hotel apartments or specialized family lounges.
Patient Consensus: Patients note that while standard rooms have strict night-time exits, paying for the family bed add-on makes a huge difference. Many families find it most practical to rent nearby apartments for long-term chemotherapy sessions to avoid hospital exhaustion.
Patients can obtain a remote second opinion for hematology oncology before traveling to China. Leading facilities like Fuda Cancer Hospital and Lu Daopei Hematology Hospital offer these services. Consultations typically use secure video platforms or written reports to validate diagnoses and treatment strategies before international travel.
Bookimed Expert Insight: Clinics with high patient volumes, such as Yanda International Hospital with 2,500,000 annual visits, often employ internal translation teams. These facilities seamlessly bridge language gaps for international cases. Choosing a JCI-accredited center like Fuda Cancer Hospital ensures that your remote consultation follows globally recognized safety and quality standards.
Patient Consensus: Patients note that sending pathology slides ahead via courier is vital for accurate remote analysis. Many find that using English-speaking coordinators helps navigate language barriers when uploading records to Chinese oncology platforms.